(Press-News.org) Open Targets, a public-private partnership dedicated to pre-competitive drug discovery research, today announced MSD, the tradename of Merck & Co., Inc., Rahway, N.J., USA, as the latest partner to join the consortium. Open Targets aims to accelerate the development of safe and effective medicines by leveraging cutting-edge technologies to identify, prioritise, and validate potential drug targets. MSD’s expertise in drug discovery will complement the strengths of the current partners: EMBL’s European Bioinformatics Institute (EMBL-EBI), the Wellcome Sanger Institute, GSK, Sanofi, Pfizer, and Genentech, a member of the Roche group.
Open Targets was founded in 2014 to help address the high attrition rates of potential new therapies in clinical trials. Retrospective analyses – including from Open Targets – show that clinical trials are more likely to succeed when the link between the disease and the drug target is supported by evidence from genetics and genomics studies. The consortium bridges the gap between academic research and pharmaceutical drug development to generate and interpret the evidence that supports decision making in drug target discovery.
Open Targets partners collaborate on innovative projects aiming to identify causal links between targets, biological pathways, and disease. The consortium’s research portfolio combines systematic, large-scale experimental techniques with cutting-edge informatics approaches and addresses all aspects of human health and disease, with a particular focus on immunology and inflammation, oncology, and neurodegeneration.
“MSD is a fantastic addition to the partnership,” said David Hulcoop, Executive Director of Open Targets. “Every new partner pushes the consortium forward and enables us to aim for more ambitious and impactful projects. With MSD’s reputation for scientific excellence, I’m excited to see what we can achieve together.”
The partnership is committed to rapid publication to openly share experimental data, informatic methods, and other knowledge generated by the consortium with the broader scientific community. In the 10 years since the partnership was founded, Open Targets has published research that provides evidence of novel target-disease associations and creates or extends data infrastructures that are foundational to the identification and prioritisation of potential drug targets.
“We are pleased to join the Open Targets consortium and believe this unique public-private model will allow us to leverage large-scale genomics data along with advances in AI and machine learning, so we can better understand the underlying drivers of disease and enable more efficient target discovery,” said Iya Khalil, Vice President and Head of Data, AI and genome sciences, MSD Research Laboratories. “We look forward to working closely with our partners at Open Targets.”
END
MSD joins the Open Targets consortium
2024-04-30
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
U of T researchers target neurogenesis in new approach to treat Parkinson’s disease
2024-04-30
Researchers at the University of Toronto have found a way to better control the preclinical generation of key neurons depleted in Parkinson’s disease, pointing toward a new approach for a disease with no cure and few effective treatments.
The researchers used an antibody to selectively activate a receptor in a molecular signaling pathway to develop dopaminergic neurons. These neurons produce dopamine, a neurotransmitter critical to brain health.
Researchers around the world have been working to coax stem cells to differentiate into dopaminergic ...
Microbiome researchers challenge the state of the art in colon cancer biomarker discovery
2024-04-30
Leuven (Belgium) 30/04/2024 - For the first time, researchers from VIB-KU Leuven, UZ Leuven, Janssen Pharmaceutica and multiple international collaborators have introduced quantitative methods and extensive confounder control to discover microbiome biomarkers in colorectal cancer development. While multiple microbial taxa have been put forward as potential cancer-associated biomarkers in the past, this new study uncovers obscured contributions that may have resulted in incorrect associations. The results have been published in Nature Medicine.
Cancer ...
Unveiling nature's custodians: groundbreaking study highlights crucial role of scavengers in wetlands
2024-04-30
A pioneering study highlights the importance of carrion and scavengers in wetlands on a global scale. A study by researchers from the Ecology area of the Miguel Hernández University of Elche (UMH) and the Ecology department of the University of Alicante (UA) reveals the fundamental importance of scavengers and carrion in wetlands. The article, published in Biological Reviews, emphasizes that the benefits provided by scavengers far outweigh the potential drawbacks. Among their essential functions are the recycling and transportation of nutrients and the regulation of water quality, benefiting the entire ecosystem, from soil and plants to birds and mammals.
Historically, ...
Data scarcity challenges identification of endocrine disruptors
2024-04-30
As a result, the researchers recommend updating the information requirements in the EU legislation, REACH. They also propose various approaches for evaluating chemical substances to ensure that all available information is fully utilized.
Researchers from DTU National Food Institute and the University of Southern Denmark have screened the scientific literature for the Danish Environmental Protection Agency to find substances showing signs of endocrine disrupting properties and thus being potentially harmful to humans and ...
A significant portion of the world’s population continues to trust vaccines, says survey in 23 countries
2024-04-30
A substantial proportion of the world’s population remains willing to get vaccinated against diseases including COVID-19, according to a new survey across 23 countries that represent more than 60% of the world’s population. The study, published in Nature Medicine, was co-led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by “la Caixa” Foundation, and the Graduate School of Public Health and Health Policy of the City University of New York (CUNY SPH).
The severe human impact of the COVID-19 pandemic led to the rapid research and development of safe and effective vaccines based on existing models, ...
Clumps of this molecule inhibit strep’s DNA-cleaving enzymes
2024-04-30
An entirely new approach to inhibiting DNA-cleaving enzymes works through the aggregation of an otherwise non-toxic molecule. This Kobe University discovery may lead to a much-needed method for curbing Streptococcus growth.
Enzymes are the body’s tools to make almost all reactions happen. But the same is true for bacteria like Streptococcus, which causes toxic shock syndrome, a rapidly progressing and deadly condition. When the body’s white blood cells try to capture the bacteria by casting nets made out ...
Cars as particles
2024-04-30
What do the flow of cars on a highway and the movement of bacteria towards a food source have in common? In both cases, annoying traffic jams can form. Especially for cars, we might want to understand how to avoid them, but perhaps we've never thought of turning to statistical physics, as Alexandre Solon, a physicist from Sorbonne Université, and Eric Bertin, from the University of Grenoble, both working for the Centre national de la recherche scientifique CNRS, have done. Their research, recently published in the Journal of Statistical Mechanics: Theory and Experiment (JSTAT), has developed a one-dimensional mathematical model ...
Let widgeongrass be a weed in the seagrass yard -- making seagrass restoration more resistant to rising temperatures using generalist grasses
2024-04-30
New research demonstrates that seagrass habitat restoration can be enhanced by including other grasses in addition to the declining or lost species and – ultimately – that restoration efforts must proactively select species that can withstand current and intensifying stressors driven by human activities and climate change.
Rising global temperatures combined with centuries of humans working within our seascapes has reshaped coastal ecosystems. Rebuilding or restoring coastal habitat is becoming ...
Group sales incentives boost weak brand sales, study finds
2024-04-30
New research co-authored by a UC Riverside business professor provides some sound advice for managers of retail outlets that limit their product selection to a particular brand: Managers should factor in the strength of their brand when structuring the pay incentives for their sales staff.
The study focused on what marketing scholars call “brand-managed” retail operations. These outlets include “stores within stores,” such as counters in major department stores with dedicated sales staff that offer just one brand of cosmetics such as Clinique. They can also be stores ...
The double-fanged adolescence of saber-toothed cats
2024-04-30
The fearsome, saber-like teeth of Smilodon fatalis — California's state fossil — are familiar to anyone who has ever visited Los Angeles' La Brea Tar Pits, a sticky trap from which more than 2,000 saber-toothed cat skulls have been excavated over more than a century.
Though few of the recovered skulls had sabers attached, a handful exhibited a peculiar feature: the tooth socket for the saber was occupied by two teeth, with the permanent tooth slotted into a groove in the baby tooth.
Paleontologist Jack Tseng, associate professor of integrative biology at the University of California, Berkeley, doesn't think the double fangs ...